Firefly Aerospace, Inc.

Thesis

Firefly's ~$1.3B backlog converts into $420–450M of 2026 revenue and compounds roughly 20–25%/yr through 2031 as Eclipse reaches launch cadence, Blue Ghost lunar deliveries become annual, and SciTec's missile-warning software rides Golden Dome funding. But at $20.70 (~6.6x EV / 2026 guided sales) that base case produces only a ~1%/yr 5-year IRR against a 3x mature-comp exit multiple — the base case is already in the price despite a 72% drawdown from the high. This is a watchlist thesis, not a buy: it becomes actionable near ~$10, or earlier if Eclipse cadence plus Golden Dome awards move the defensible base toward ~$2B of 2031 revenue.

Why Now

The revenue inflection is real and filed, not promised. FY2025 revenue was $159.9M, up 163% year-over-year, with Q4 2025 alone at $57.7M versus $9.0M a year earlier (10-K FY2025, period ended 2025-12-31). Q1 2026 accelerated again to $80.9M — up 44.7% y/y and 40% sequentially — split $67.6M Spacecraft Solutions and $13.3M Launch (10-Q Q1 FY2026, period ended 2026-03-31, and the accompanying May 2026 earnings release). Management reiterated 2026 guidance of $420–450M against a total backlog of roughly $1.3B, flat sequentially — meaning bookings are keeping pace even as recognition ramps 2.6–2.8x over 2025.

Three structural events sit behind the ramp. First, the $855M acquisition of SciTec closed 2025-11-05 (8-K): $300M cash plus ~$555M of stock issued at $50/share, bringing ~$164M of trailing national-security revenue in missile-warning and space-domain-awareness data processing — the piece that makes Firefly a named Golden Dome participant (SciTec supplies fire-control and ground-segment software; Golden Dome received its initial ~$25B appropriation in the July 2025 reconciliation act). Second, Alpha returned to flight successfully in spring 2026 (Flight 7) after two 2025 failures, with the upgraded Block 2 debut targeted for late summer and three more launches guided for 2026. Third, lunar demand is compounding: a $144M NASA CLPS task order awarded 2026-06-30 for an accelerated 2028 Blue Ghost mission, a $13M Mars SkyFall aeroshell subcontract, and a DoD/DIU Elytra on-orbit mission slated for 2027.

The reason the name is on the desk now is price, not fundamentals. Firefly sold 4M primary and 8M secondary shares at $48.00 on 2026-05-29 (424B4); seven weeks later the stock closed at $20.70 (2026-07-23) — down 57% from the offering and 72% from the $73.80 high — on supply overhang, resale registrations, 13% short interest of float, and a sector-wide derating, with no operational miss in between. That is a genuine dislocation. The honest problem, worked through below, is that even the post-crash price still fully discounts a defensible base case.

Business Quality

Firefly's moat is narrow but real in two places. Blue Ghost Mission 1 (March 2025) remains the only fully successful commercial soft landing on the Moon, and NASA has responded with repeat business — the June 2026 award was Firefly's fourth lunar delivery, priced around $144M per mission, with the company compressing build time to roughly two years per lander from a dedicated Austin-area spacecraft facility. SciTec is the second: entrenched, hard-to-displace ground software for missile warning and overhead persistent infrared, exactly the layer Golden Dome must buy. Launch is the weakest leg — Alpha has three full successes in seven attempts, and the medium-lift Eclipse (co-developed with Northrop Grumman, which is both partner and anchor customer as its Antares successor) has yet to fly, targeted "late 2026" and realistically 2027.

Unit economics are early-stage: Q1 2026 GAAP gross margin was 21.6% (down from 27.7% the prior quarter on mix), GAAP operating loss $95.7M, and FY2025 free cash flow was −$237.8M against adjusted EBITDA of −$198.6M. The counterweight is a clean balance sheet: $551.6M cash and short-term investments against ~$53M of debt at 3/31/26, $811.6M total liquidity including a $260M undrawn revolver, plus ~$184M net primary proceeds from the June offering — roughly 2.5–3 years of runway at the current burn, likely more as guidance implies burn moderation into 2027.

Capital allocation is the open question. Paying $855M (~5.2x trailing revenue) for SciTec was strategically coherent — it diversified the company away from binary launch risk into recurring defense software and bought Golden Dome relevance — but it was funded substantially with stock issued at $50 that now trades at $20.70, and it layered ~$700M+ of goodwill and intangibles onto the balance sheet. Competition is severe on every axis: SpaceX rideshare compresses small-launch pricing beneath Alpha, Rocket Lab's Neutron races Eclipse to the medium-lift gap, and Blue Origin and Intuitive Machines contest lunar delivery. Firefly's edge is that it is the only mid-cap with all three legs — launch, landers, and defense software — under one roof; the risk is that three capital-hungry programs at once is exactly how mid-caps burn out.

Financial Base

Reference figures as of 2026-07-23: trailing-twelve-month revenue of $185M, 170.0M diluted shares, net debt of $-499M, and a share price of $20.70. Sources:

• 10-Q Q1 FY2026 (period ended 2026-03-31, filed May 2026, SEC accession 0001860160-26-000009) — revenue $80.9M; cash + short-term investments $551.6M; 160,067,383 shares outstanding on cover; total debt incl. finance leases ~$53M
• 10-K FY2025 (period ended 2025-12-31, filed March 2026) — FY2025 revenue $159.855M (+163% y/y); Q4 2025 revenue $57.673M; net loss $298.3M; adjusted EBITDA −$198.6M; free cash flow −$237.8M
• Q1 FY2026 earnings release (May 2026) — backlog ~$1.3B flat q/q; 2026 revenue guidance $420–450M reiterated; total liquidity $811.6M ($551.6M cash/ST investments + $260M revolver)
• 424B4 prospectus, offering priced 2026-05-29 — 4.0M primary + 8.0M secondary shares at $48.00; ~$184M net primary proceeds (post-3/31 balance sheet, not in net-debt figure above)
• 8-K filed on/about 2025-11-05 — SciTec acquisition closed: $855M total, $300M cash + ~$555M in stock at $50/share; SciTec trailing revenue ~$164M (12 months to June 2025)
• Price $20.70 = Nasdaq close 2026-07-23 (stockanalysis.com); shares outstanding 164.24M post-offering; TTM revenue cross-check $184.88M = Q2'25 $15.5M (derived) + Q3'25 $30.8M + Q4'25 $57.7M + Q1'26 $80.9M

Scenario Valuation

Five-year scenario ranges under the published methodology — the tables below are computed from these exact parameters at publication and sealed with this text. What each scenario assumes:

• Loss (12%): Compounded failures — Alpha Block 2 loss, Eclipse slip past 2028 or failure, a lunar mishap, CLPS wind-down — force down-round financing. The floor is not zero: ~$3/share of net cash plus SciTec's standalone defense-software value (bought for $855M) support roughly a third of today's price.
• Bear (28%): 2026 lands near guide but growth stalls: Eclipse slips repeatedly, Alpha stays subscale against SpaceX rideshare, lunar cadence stays at one mission every 18–24 months. 2031 revenue ~$700M, valued at 1.8x EV/S — the mature defense-prime band (Lockheed/Northrop ~1.5–2.5x) — with 5%/yr dilution from raises at depressed prices.
• Base (40%): Guidance hit, then ~23%/yr from the 2026 base (the 46.5% CAGR off TTM is mostly the SciTec-annualization step): Eclipse flying by 2028, roughly annual lunar missions, SciTec growing high-teens on Golden Dome. 2031 revenue ~$1.25B still growing ~20%, valued at 3.0x EV/S — a blend of defense primes (~2x) and higher-margin defense software (~4x), well below today's froth.
• Bull (20%): Eclipse reaches ~8–12 flights/yr by 2030–31 (~$500M+ launch revenue), Golden Dome makes SciTec a program-of-record fire-control layer, and Elytra wins recurring DoD constellation work. 2031 revenue ~$2.1B at 4.0x EV/S — top-quartile defense-tech-at-scale multiple for a 25%+ grower with a software mix, still below where current-era space names trade.

Published range (present value): $5.03 – $26.73 · probability-weighted expected value $12.94 against $20.70 at drafting (0.62×) · base-case IRR +0.8%/yr. Gates: base IRR ≥ 15% and EV ≥ 1.3× — both passed at publication. Ranges are graded at the 1-year checkpoint and the 5-year horizon. This is a range, not a target.

Sensitivity — present value across growth × exit multiple

The shaded cell is the one today's price of $20.70 most closely implies. Find your own cell — we show our work rather than assert a number.

Kill Conditions

1. 1. Total backlog reported below $1.0B for two consecutive quarters (versus ~$1.3B at Q1 FY2026) — demand thesis broken.
2. 2. 2026 revenue guidance cut below $380M at any quarterly report, or FY2026 actual revenue below $380M (versus $420–450M guided).
3. 3. Fewer than three Alpha launches completed in calendar 2026, or a Block 2 (Flight 8) mission failure — launch leg loses credibility.
4. 4. No Eclipse first-launch attempt disclosed by 2027-12-31 in filings or company updates — base case requires Eclipse revenue by 2028.
5. 5. Cash plus short-term investments below $250M in any 10-Q without a committed financing in place (operating cash burn ran ~$211M over the trailing twelve months).
6. 6. Spacecraft Solutions segment revenue declines year-over-year for two consecutive quarters — the SciTec/Golden Dome growth leg failing.

Risk Register

• Cash burn — HIGH: FY2025 FCF was −$237.8M and TTM operating cash flow −$211M; runway is ~2.5–3 years, so a delayed ramp forces dilution at unfavorable prices.
• Launch failure — HIGH: Alpha is 3-for-7 on full mission success with two 2025 failures plus a ground-test booster loss; a Block 2 failure would hit both revenue and the Eclipse narrative.
• Eclipse execution — HIGH: first flight targeted 'late 2026' is likely 2027; Rocket Lab's Neutron is racing for the same medium-lift gap, and the base case leans on Eclipse revenue by 2028.
• Share-supply overhang — MEDIUM/HIGH: SciTec sellers hold ~11.1M shares issued at $50, AE Industrial retains a large sponsor stake, and resale registrations plus 13% short-of-float drove the 57% post-offering slide; more supply can cap any recovery.
• Customer concentration — MEDIUM: NASA and DoD dominate backlog; CLPS program politics, Artemis restructuring, or Golden Dome re-scoping would directly hit bookings.
• Goodwill/integration — MEDIUM: SciTec at ~5.2x trailing revenue loaded ~$700M+ of goodwill/intangibles; an impairment would not burn cash but would validate the overpayment critique.
• Competition — MEDIUM: SpaceX rideshare compresses small-launch pricing; Blue Origin and Intuitive Machines contest lunar delivery; primes could in-source Golden Dome ground software.

Theme Position

Firefly is effectively a 100%-exposure space-economy name: every revenue dollar comes from launch (Alpha, Eclipse), lunar and in-space vehicles (Blue Ghost, Elytra, Ocula imaging), or national-security space software (SciTec's missile-warning and space-domain-awareness processing, the Golden Dome hook). Q1 FY2026 split was $67.6M Spacecraft Solutions (84%) versus $13.3M Launch (16%), so today it is better understood as a defense-space-systems company with a launch option attached — which is also what makes the $1.3B backlog more bankable than a pure launch book.

Alternatives considered. Rocket Lab (RKLB): the execution leader in the category with proven cadence, but its valuation already embeds flawless Neutron execution — no dislocation to buy, and the gates fail there even harder on any mature-multiple exit. Intuitive Machines (LUNR): the closest lunar pure-play, but concentrated in CLPS/NSNS awards with no equivalent defense-software leg and a weaker balance sheet; Firefly is the higher-quality expression of the same lunar thesis. Legacy primes (Northrop, Lockheed, L3Harris) as Golden Dome plays: real program exposure but diluted to a single-digit percentage of revenue — no torque to the theme. Firefly was retained as the best risk/reward expression of the launch-plus-lunar-plus-Golden-Dome angle; the failure is price, not selection.

Benchmark

Beating means FLY total return exceeds Invesco QQQ total return over the full five-year window from publication (2026-07-24 to 2031-07-24). Success means beating QQQ's total window return from publication; the scoreboard grades this thesis against that bar, live, whether we like the answer or not.